Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Pharmacogenomic Variants May Influence the Urinary Excretion of Novel Kidney Injury Biomarkers in Patients Receiving Cisplatin

UNC Libraries(2020)10.17615/4xwv-h732Source: DataRank Database

Pharmacogenomic Variants May Influence the Urinary Excretion of Novel Kidney Injury Biomarkers in Patients Receiving Cisplatin is a research paper published in UNC Libraries (2020). On theSindex it has a DataRank of 0.189. It has been cited 1 time, with 1 citing works in its 1-hop citation network.

N/A

0.189DataRank · unranked

Scored on demand from live citation data

Open Access1 citations · 1 citing works in its network

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.13)OA: greenTopics (46)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 55%Citation Network 45%

Base Score Contribution

0.104

From this paper's citation signal

Citation Network Contribution

0.0849

From 1 citing papers with measurable signal

Learn more about DataRank methodology →

Top 1 citer driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 1 citer.

Risk factors for cisplatin‑induced acute kidney injury: A pilot study on the usefulness of genetic variants for predicting nephrotoxicity in clinical practice
Molecular and Clinical Oncology202010 citations24 referencesContributes 0.100

Authors (11)

Cindy L. O’Bryant ORCID,Madeleine Gomez,Melanie S. Joy ORCID,Susan L. Hogan ORCID,Daniel W. Bowles ORCID

Live enrichment

PubMed:21097893 OpenAlex:https://openalex.org/W4300262466

National Institutes of Health

Grant: 2T32ES007148-06

TRAINING IN EVIRONMENTAL TOXICOLOGY

National Institutes of Health

Grant: 4R00DK080774-02

Protective Role of Mrp2 During Chemotherapy-Induced Kidney Injury

National Institutes of Health

Grant: 5P30ES005022-18

Research Center in Environmental Health Sciences

FWCI

0.13

Citation Percentile

0.5%

Citation Trend

2020

greenLicense: CC BY

repositoryhttps://doi.org/10.17615/4xwv-h732

https://doi.org/10.3390/ijms18071333

https://www.mdpi.com/1422-0067/18/7/1333/pdf

https://dx.doi.org/10.17615/4xwv-h732

https://pubmed.ncbi.nlm.nih.gov/28640195

Fields of Study

Chemotherapy-induced organ toxicity mitigationElectrolyte and hormonal disordersPharmacological Effects and Toxicity Studies0301 basic medicine03 medical and health sciences0303 health sciences

Keywords

PharmacogenomicsUrinary systemCisplatinMedicineAcute kidney injuryRenal injuryExcretionKidneyInternal medicineBioinformaticsPharmacologyBiologyChemotherapyAdultMaleATP-Binding Cassette, Sub-Family C ProteinsOrganic Cation Transport ProteinsPharmacogenomic VariantsAntineoplastic AgentsOCT2ArticleNRF2HumansGSTCation Transport ProteinsAgedCopper Transporter 1nephrotoxicityMRP2CTR1Organic Cation Transporter 2MATE1Middle AgedMultidrug Resistance-Associated Protein 2KEAP1Glutathione S-Transferase piGGT1FemaleBiomarkersGlomerular Filtration Rate

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being